04:36 AM EDT, 08/25/2026 (MT Newswires) -- Aiforia Technologies (AIFORIA.HE) will collaborate with breast cancer diagnostics company Stratipath to streamline workflows and expand artificial intelligence-driven oncology diagnostics. The medical software company said Tuesday the partnership will see the incorporation of Stratipath's AI-based breast cancer risk profiling technology into Aiforia's breast cancer suite, as well as possible joint market projects.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.